758 related articles for article (PubMed ID: 32496241)
1. Hydroxychloroquine as prophylaxis or treatment for COVID-19: What does the evidence say?
Nina PB; Dash AP
Indian J Public Health; 2020 Jun; 64(Supplement):S125-S127. PubMed ID: 32496241
[TBL] [Abstract][Full Text] [Related]
2. COVID-19 and Antimalarial Drugs: Harms Outweigh Benefits.
Halm MA
Am J Crit Care; 2020 Nov; 29(6):489-492. PubMed ID: 32839815
[No Abstract] [Full Text] [Related]
3. Impact of Hydroxychloroquine/Chloroquine in COVID-19 Therapy: Two Sides of the Coin.
Fatima U; Rizvi SSA; Fatima S; Hassan MI
J Interferon Cytokine Res; 2020 Oct; 40(10):469-471. PubMed ID: 32881593
[TBL] [Abstract][Full Text] [Related]
4. Experience With Hydroxychloroquine and Azithromycin in the Coronavirus Disease 2019 Pandemic: Implications for QT Interval Monitoring.
Ramireddy A; Chugh H; Reinier K; Ebinger J; Park E; Thompson M; Cingolani E; Cheng S; Marban E; Albert CM; Chugh SS
J Am Heart Assoc; 2020 Jun; 9(12):e017144. PubMed ID: 32463348
[TBL] [Abstract][Full Text] [Related]
5. QT Interval Control to Prevent Torsades de Pointes during Use of Hydroxychloroquine and/or Azithromycin in Patients with COVID-19.
Wu TC; Sacilotto L; Darrieux FCDC; Pisani CF; Melo SL; Hachul DT; Scanavacca M
Arq Bras Cardiol; 2020 Jun; 114(6):1061-1066. PubMed ID: 32638906
[No Abstract] [Full Text] [Related]
6. Ventricular arrhythmia risk due to chloroquine / hydroxychloroquine treatment for COVID-19: Should it be given.
Malviya A
Indian Heart J; 2020; 72(2):131-132. PubMed ID: 32534688
[No Abstract] [Full Text] [Related]
7. Acute meningoencephalitis in a patient with COVID-19.
Chaumont H; Etienne P; Roze E; Couratier C; Roger PM; Lannuzel A
Rev Neurol (Paris); 2020 Jun; 176(6):519-521. PubMed ID: 32414534
[No Abstract] [Full Text] [Related]
8. [Hydroxychloroquine and chloroquine for COVID-19: no evidence of effectiveness].
Vollaard A; Gieling EM; van der Linden PD; Sinha B; de Boer MGJ
Ned Tijdschr Geneeskd; 2020 Jun; 164():. PubMed ID: 32749808
[TBL] [Abstract][Full Text] [Related]
9. Regulators split on antimalarials for COVID-19.
Jaffe S
Lancet; 2020 Apr; 395(10231):1179. PubMed ID: 32278373
[No Abstract] [Full Text] [Related]
10. Hydroxychloroquine and Azithromycin to Treat Patients With COVID-19: Both Friends and Foes?
Mégarbane B; Scherrmann JM
J Clin Pharmacol; 2020 Jul; 60(7):808-814. PubMed ID: 32434282
[No Abstract] [Full Text] [Related]
11. Effect of Chloroquine, Hydroxychloroquine, and Azithromycin on the Corrected QT Interval in Patients With SARS-CoV-2 Infection.
Saleh M; Gabriels J; Chang D; Soo Kim B; Mansoor A; Mahmood E; Makker P; Ismail H; Goldner B; Willner J; Beldner S; Mitra R; John R; Chinitz J; Skipitaris N; Mountantonakis S; Epstein LM
Circ Arrhythm Electrophysiol; 2020 Jun; 13(6):e008662. PubMed ID: 32347743
[TBL] [Abstract][Full Text] [Related]
12. Proactive prophylaxis with azithromycin and hydroxychloroquine in hospitalized patients with COVID-19 (ProPAC-COVID): a statistical analysis plan.
Sivapalan P; Ulrik CS; Lappere TS; Eklöf JV; Shaker SB; Bødtger UCS; Browatzki A; Meyer CN; Weinreich UM; Laursen CB; Biering-Sørensen T; Knop FK; Lundgren JD; Jensen JS
Trials; 2020 Oct; 21(1):867. PubMed ID: 33081817
[TBL] [Abstract][Full Text] [Related]
13. Hydroxychloroquine and azithromycin tolerance in haemodialysis patients during COVID-19 infection.
Giaime P; Guenoun M; Pedinielli N; Narbonne H; Bergounioux JP; Solas C; Guilhaumou R; Sampol J; Ollier J; Sichez H; Serveaux M; Brunner F; Bataille S
Nephrol Dial Transplant; 2020 Aug; 35(8):1346-1353. PubMed ID: 32844224
[TBL] [Abstract][Full Text] [Related]
14. Rheumotologitsts' view on the use of hydroxychloroquine to treat COVID-19.
Sun X; Ni Y; Zhang M
Emerg Microbes Infect; 2020 Dec; 9(1):830-832. PubMed ID: 32338155
[TBL] [Abstract][Full Text] [Related]
15. [Is there a need for ophthalmological surveillance in the case of short-term hydroxychloroquine treatment during this COVID-19 pandemic?].
Defoort-Dhellemmes S
J Fr Ophtalmol; 2020 Jun; 43(6):548-549. PubMed ID: 32451138
[No Abstract] [Full Text] [Related]
16. Risk of using hydroxychloroquine as a treatment of COVID-19.
Alanagreh L; Alzoughool F; Atoum M
Int J Risk Saf Med; 2020; 31(3):111-116. PubMed ID: 32474476
[TBL] [Abstract][Full Text] [Related]
17. Assessment of QT Intervals in a Case Series of Patients With Coronavirus Disease 2019 (COVID-19) Infection Treated With Hydroxychloroquine Alone or in Combination With Azithromycin in an Intensive Care Unit.
Bessière F; Roccia H; Delinière A; Charrière R; Chevalier P; Argaud L; Cour M
JAMA Cardiol; 2020 Sep; 5(9):1067-1069. PubMed ID: 32936266
[TBL] [Abstract][Full Text] [Related]
18. Chloroquine as a prophylactic agent against COVID-19?
Gendrot M; Javelle E; Clerc A; Savini H; Pradines B
Int J Antimicrob Agents; 2020 Jun; 55(6):105980. PubMed ID: 32294495
[TBL] [Abstract][Full Text] [Related]
19. A Case of Breakthrough COVID-19 during Hydroxychloroquine Maintenance.
Ahn BY; Kang CK; Seo JD; Choe PG; Song SH; Park WB; Park SW; Kim NJ; Oh MD
J Korean Med Sci; 2020 Jun; 35(24):e231. PubMed ID: 32567262
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic use of chloroquine and hydroxychloroquine in COVID-19 and other viral infections: A narrative review.
Hashem AM; Alghamdi BS; Algaissi AA; Alshehri FS; Bukhari A; Alfaleh MA; Memish ZA
Travel Med Infect Dis; 2020; 35():101735. PubMed ID: 32387694
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]